advertisement
Editors Selection IGR 26-1
List of Editor's Selection comments by
Tina Wong
Ocular Therapeutics and Drug Delivery, Singapore Eye Research Institute and the Singapore National Eye Centre, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore
Glaucoma and Systemic Diseases: Glaucoma linked to circadian rhythm sleep disorders in millions (25-4, April 2026) on:
127125 The Associations Between Glaucoma and Circadian Rhythm Sleep Disorders in California Medicare Beneficiaries
Ramirez M; Kitayama K; Kitayama K; Puran A et al.
American Journal of Ophthalmology 2025; 278: 250-256
Quality of Life: Primary Surgery Preserves Quality of Life in Advanced Glaucoma (22-2, December 2021) on:
94530 Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS)
King AJ; Hudson J; Fernie G et al.
British Medical Journal (Clinical Research Edition) 2021; 373: n1014
Basic Science: A new potential pathogenic pathway (18-1, February 2017) on:
69029 Pro-fibrotic pathway activation in trabecular meshwork and lamina cribrosa is the main driving force of glaucoma
Zhavoronkov A; Kanherkar RR; Izumchenko E et al.
Cell cycle (Georgetown, Tex.) 2016; 15: 1643-1652
Medical Treatment: Investigational drugs (16-4, September 2015) on:
60083 A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study
Weinreb RN; Ong T; Scassellati Sforzolini B et al.
British Journal of Ophthalmology 2015; 99: 738-745
Medical Treatment: Drug delivery (16-4, September 2015) on:
60294 Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure
Lambert WS; Carlson BJ; van der Ende AE et al.
Translational vision science & technology 2015; 4: 1
Basic Science: Source of VEGF in neovascular glaucoma (16-3, June 2015) on:
58858 Human ciliary epithelium as a source of synthesis and secretion of vascular endothelial growth factor in neovascular glaucoma
Chalam KV; Brar VS; Murthy RK
JAMA ophthalmology 2014; 132: 1350-1354
Medical Treatment: Long-lasting drug delivery (16-2, March 2015) on:
57479 28-day intraocular pressure reduction with a single dose of brimonidine tartrate-loaded microspheres
Fedorchak MV; Conner IP; Medina CA et al.
Experimental Eye Research 2014; 125: 210-216
Surgical treatment: Drug-delivery implant (16-2, March 2015) on:
57435 Evaluation of an injectable thermosensitive hydrogel as drug delivery implant for ocular glaucoma surgery
Xi L; Wang T; Zhao F et al.
PLoS ONE 2014; 9: e100632
Medical Treatment: Extended delivery by contact lens (15-4, September 2014) on:
55170 In vivo performance of a drug-eluting contact lens to treat glaucoma for a month
Ciolino JB; Stefanescu CF; Ross AE et al.
Biomaterials 2014; 35: 432-439
Basic Research: Senescence of TM cells by TGF-beta2 (12-4, March 2011) on:
26956 TGF-{beta}2 induces senescence-associated changes in human trabecular meshwork cells.
Yu AL; Birke K; Moriniere J et al.
Investigative Ophthalmology and Visual Science 2010; 51: 5718-5723
Comments (12-2, September 2010) on:
26161 Adenoviral gene transfer of active human transforming growth factor-{beta}2 elevates intraocular pressure and reduces outflow facility in rodent eyes
Shepard AR; Millar JC; Pang IH et al.
Investigative Ophthalmology and Visual Science 2010; 51: 2067-2076
Comments (11-4, March 2010) on:
24877 Three-year follow-up of the tube versus trabeculectomy study
Gedde SJ; Schiffman JC; Feuer WJ et al.
American Journal of Ophthalmology 2009; 148: 670-684
Surgery: Bevacizumab in avascular blebs (10-4, March 2009) on:
22406 Vascular changes after intra-bleb injection of bevacizumab
Coote MA; Ruddle JB; Qin Q et al.
Journal of Glaucoma 2008; 17: 517-518
(Laser) Surgical treatment: MMPs and woundhealing (9-4, March 2008) on:
20012 Expression of matrix metalloproteinases in wound healing after glaucoma filtration surgery in rabbits
Shima I; Katsuda S; Ueda Y et al.
Ophthalmic Research 2007; 39: 315-324
Basic research: Trabecular meshwork: Senescence of TM cells (9-2, September 2007) on:
18091 Senescence in cultured trabecular meshwork cells
Yamazaki Y; Matsunaga H; Nishikawa M et al.
British Journal of Ophthalmology 2007; 91: 808-811
Surgical treatment: Biodegradable matrix (8-4, March 2007) on:
15102 Control of filtering bleb structure through tissue bioengineering: An animal model
Chen HS; Ritch R; Krupin T et al.
Investigative Ophthalmology and Visual Science 2006; 47: 5310-5314
Surgery: Antifibrosis (8-3, December 2006) on:
14045 Potential role of tissue transglutaminase in glaucoma filtering surgery
Priglinger SG; Alge CS; Kook D et al.
Investigative Ophthalmology and Visual Science 2006; 47: 3835-3845
